Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.65 USD | +1.34% | -6.57% | -12.82% |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Apr. 04 | Traws Pharma, Inc. Announces Chief Executive Office Changes | CI |
Business Summary
Number of employees: 18
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oncology Therapeutics
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | 0.00% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | 0.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Fruchtman
PSD | President | 73 | 15-01-18 |
Mark Guerin
DFI | Director of Finance/CFO | 55 | 13-08-31 |
Meena Arora
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-23 |
Victor Moyo
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-23 |
Matthew Parris
CTO | Chief Tech/Sci/R&D Officer | - | 18-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Marino
BRD | Director/Board Member | 74 | 15-06-30 |
Jack Stover
BRD | Director/Board Member | 69 | 16-05-22 |
Mary Shoemaker
BRD | Director/Board Member | 63 | 20-03-31 |
Steven Fruchtman
PSD | President | 73 | 15-01-18 |
Trafford Clarke
BRD | Director/Board Member | 66 | 22-12-18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,301,009 | 20,518,488 ( 81.10 %) | 0 | 81.10 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.82% | 13.52M | |
+2.17% | 43.84B | |
+7.45% | 41.68B | |
+45.04% | 41.25B | |
-10.92% | 27.04B | |
+5.44% | 25.53B | |
-25.49% | 18.18B | |
-2.88% | 12.29B | |
+26.51% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- TRAW Stock
- Company Traws Pharma, Inc.